Equity Overview
Price & Market Data
Price: $19.68
Daily Change: -$0.479 / 2.44%
Range: $19.20 - $20.03
Market Cap: $14,689,933,312
Volume: 2,892,964
Performance Metrics
1 Week: -3.93%
1 Month: -13.05%
3 Months: -4.86%
6 Months: 10.07%
1 Year: 162.3%
YTD: 10.84%
Company Details
Employees: 159
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.